Severity
Critical
FDA Drug recall · Reported February 13, 2013
Marketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons,…
Globe All Wellness, LLC recalled SLIM XTREME Herbal Slimming Capsule, supplied in 30-count bottles. Another Product Forumu… - a critical-severity action.
SLIM XTREME Herbal Slimming Capsule, supplied in 30-count bottles. Another Product Forumu… was recalled by Globe All Wellness, LLC in February 13, 2013. Reason: Marketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that …. Check the official notice for the remedy. Verify recall #D-148-2013 with the FDA Drug before acting.
The recall
Globe All Wellness, LLC issued this critical-severity FDA Drug recall-Marketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that ….
Sourced from official FDA Drug enforcement records. Verify recall #D-148-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-148-2013) was formally reported on February 13, 2013, with the manufacturer initiating the action on September 20, 2012. It is classified under Critical severity (Class I), with a current status of Terminated. Globe All Wellness, LLC is listed as the recalling firm, operating out of Hollywood, FL. Federal records list the affected scope as 40,400 bottles.
The documented reason for this recall is: Marketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, making this product an unapproved new d… Distribution data in the federal record shows the product reached: Nationwide and Puerto Rico and internationally to Barbados, Brazil, Canada, Cyprus, Equador, France, Germany, Israel, Mexico, and Netherlands.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
40,400 bottles
Related Recalls
6
5 from same agency
SLIM XTREME Herbal Slimming Capsule, supplied in 30-count bottles. Another Product Forumulated and Distributed By: Globe All Wellness, LLC Hollywood, FL 33020 www.diet66.com Inquires Call 877.842.9873
Marketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, making this product an unapproved new drug.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-148-2013 |
| Date reported | February 13, 2013 |
| Date initiated | September 20, 2012 |
| Recalling firm | Globe All Wellness, LLC |
| Firm location | Hollywood, FL |
| Affected scope | 40,400 bottles |
| Distribution | Nationwide and Puerto Rico and internationally to Barbados, Brazil, Canada, Cyprus, Equador, France, Germany, Israel, Mexico, and Netherlands. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 13, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.